🟢 Immunitybio is trading 10.18% up today as biotech shares rally after Fed decision

Immunitybio is trading 10.18% up at $8.71 as biotechnology shares and broader markets rally after the September 16, 2026 Federal Reserve decision.

• The biotech sector is up 2.55%, while the Nasdaq and S&P 500 are firmly higher, supporting risk appetite.
• No new September 17 company-specific announcement was identified.
• Nant Capital’s PDS Biotech investment and Patrick Soon-Shiong’s board appointment pushed shares higher on September 14, but the report does not directly explain this session’s move.